PB

Perseus-Soros Biopharmaceutical Fund

North America, New York, United States, New York

Description

Perseus-Soros Biopharmaceutical Fund, L.P. specializes in equity investments in private and public life science companies.

Investor Profile

Perseus-Soros Biopharmaceutical Fund has made 21 investments, with 0 in the past 12 months and 29% as lead.

Stage Focus

  • Series D (29%)
  • Series B (24%)
  • Series Unknown (14%)
  • Series C (14%)
  • Series E (10%)
  • Series A (5%)
  • Private Equity (5%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Biopharma
  • Medical
  • Therapeutics
  • Medical Device
  • Market Research
  • Developer Platform
  • Health Diagnostics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Perseus-Soros Biopharmaceutical Fund frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 4
China Development Industrial Bank (CDIB)
Asia, T'ai-pei, Taiwan, Taipei
Co-Investments: 3
HealthCare Ventures
North America, Massachusetts, United States, Cambridge
Co-Investments: 6
Avalon Ventures
North America, California, United States, La Jolla
Co-Investments: 3
Burrill & Company
North America, California, United States, San Francisco
Co-Investments: 4
Montreux Equity Partners
North America, California, United States, San Francisco
Co-Investments: 4
GeneChem
North America, Quebec, Canada, Montréal
Co-Investments: 4
Forward Ventures
North America, California, United States, San Diego
Co-Investments: 3
Schroder Ventures
Europe, England, United Kingdom, London
Co-Investments: 3
Aisling Capital
North America, New York, United States, New York
Co-Investments: 4

What are some of recent deals done by Perseus-Soros Biopharmaceutical Fund?

Xanodyne

Newport, Kentucky, United States

Xanodyne Pharmaceuticals is an integrated specialty pharmaceutical company focused on women’s healthcare and pain management.

BiotechnologyHealth CarePharmaceutical
Series UnknownOct 30, 2009
Amount Raised: $87,783,861
CeNeRx BioPharma

Cary, North Carolina, United States

CeNeRx BioPharma, a drug development company, engages in developing therapeutics to treat diseases related to the nervous system.

BiopharmaBiotechnologyTherapeutics
Series BSep 29, 2008
Amount Raised: $15,000,000
Ambit Biosciences

San Diego, California, United States

Ambit Biosciences, a biopharmaceutical company, develops small molecule kinase inhibitors for cancer and inflammatory disease treatments.

BiopharmaBiotechnologyHealth Care
Series DNov 14, 2007
Amount Raised: $49,300,000
Cardiokine

Philadelphia, Pennsylvania, United States

Cardiokine, Inc., a specialty pharmaceutical company, engages in the development of pharmaceuticals for the prevention and treatment of

BiotechnologyHealth CarePharmaceutical
Series BMay 1, 2006
Amount Raised: $50,000,000
SkinMedica

Carlsbad, California, United States

SkinMedica is focused on developing, acquiring, and commercializing products that improve the appearance of skin.

BiotechnologyMedicalMedical Device
Series EApr 12, 2006
Amount Raised: $11,000,000
Ambit Biosciences

San Diego, California, United States

Ambit Biosciences, a biopharmaceutical company, develops small molecule kinase inhibitors for cancer and inflammatory disease treatments.

BiopharmaBiotechnologyHealth Care
Series CMay 12, 2005
Amount Raised: $31,000,000
SkinMedica

Carlsbad, California, United States

SkinMedica is focused on developing, acquiring, and commercializing products that improve the appearance of skin.

BiotechnologyMedicalMedical Device
Series EApr 6, 2005
Amount Raised: $15,000,000
ArgiNOx Phamaceuticals

Redwood City, California, United States

Arginox Pharmaceuticals is a biopharmaceutical company engaged in the discovery and development of drugs for cardiovascular pathologies.

BiotechnologyHealth CareMedicalPharmaceutical
Series CMar 2, 2005
Amount Raised: $25,000,000
Avera Pharmaceutical

San Diego, California, United States

Avera Pharmaceuticals is a specialty pharmaceutical company that acquires, develops, and commercializes pharmaceutical compounds.

Health CareMedicalPharmaceutical
Series CAug 5, 2004
Amount Raised: $48,000,000
SkinMedica

Carlsbad, California, United States

SkinMedica is focused on developing, acquiring, and commercializing products that improve the appearance of skin.

BiotechnologyMedicalMedical Device
Series DJul 14, 2004
Amount Raised: $30,000,000